{"filing":{"accession_number":"0001193125-26-326149","cik":"0001308547","ticker":"DLB","company_name":"Dolby Laboratories, Inc.","form":"8-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"d165402d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526326149/d165402d8k.htm"},"events":[{"id":22612,"run_id":20458,"accession_number":"0001193125-26-326149","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Dolby Laboratories issued a press release on July 30, 2026 announcing its financial results for the fiscal quarter ended June 26, 2026, including total revenue of $305M, GAAP and non-GAAP net income, and forward guidance for Q4 and full-year fiscal 2026.","company_name":"Dolby Laboratories, Inc.","ticker":"DLB","filing_date":"2026-07-30","form":"8-K","submitted_at":null,"items":[{"id":22602,"accession_number":"0001193125-26-326149","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Dolby Laboratories' third quarter fiscal 2026 financial results. The Item 2.02 disclosure explicitly states \"On July 30, 2026, Dolby Laboratories, Inc. (the 'Company') issued a press release announcing its financial results for its fiscal quarter ended June 26, 2026.\" The press release provides detailed quarterly financial highlights including total revenue ($305M vs. $316M prior year), GAAP and non-GAAP net income, and forward guidance for Q4 and full-year fiscal 2026, along with business highlights and dividend/repurchase announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:23:32.617629+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":22613,"run_id":20458,"accession_number":"0001193125-26-326149","anchor_item_number":"8.01","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"Dolby Laboratories declared a cash dividend of $0.36 per share payable on August 19, 2026, and announced a $350 million increase to its stock repurchase authorization.","company_name":"Dolby Laboratories, Inc.","ticker":"DLB","filing_date":"2026-07-30","form":"8-K","submitted_at":null,"items":[{"id":22603,"accession_number":"0001193125-26-326149","item_number":"8.01","item_title":null,"event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Item 8.01 disclosure announces two distinct capital allocation events: (1) a cash dividend of $0.36 per share payable August 19, 2026, and (2) a $350 million increase to the stock repurchase authorization. While both are material shareholder returns, the dividend declaration is the primary event disclosed in the opening paragraph and is explicitly labeled \"Declaration of Dividend.\" The repurchase authorization increase is secondary. Dividend distributions are material to investors assessing capital allocation and shareholder returns.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:23:32.617629+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22602,"accession_number":"0001193125-26-326149","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Dolby Laboratories' third quarter fiscal 2026 financial results. The Item 2.02 disclosure explicitly states \"On July 30, 2026, Dolby Laboratories, Inc. (the 'Company') issued a press release announcing its financial results for its fiscal quarter ended June 26, 2026.\" The press release provides detailed quarterly financial highlights including total revenue ($305M vs. $316M prior year), GAAP and non-GAAP net income, and forward guidance for Q4 and full-year fiscal 2026, along with business highlights and dividend/repurchase announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:23:32.617629+00:00","company_name":"Dolby Laboratories, Inc.","ticker":"DLB","filing_date":"2026-07-30"},{"id":22603,"accession_number":"0001193125-26-326149","item_number":"8.01","item_title":null,"event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Item 8.01 disclosure announces two distinct capital allocation events: (1) a cash dividend of $0.36 per share payable August 19, 2026, and (2) a $350 million increase to the stock repurchase authorization. While both are material shareholder returns, the dividend declaration is the primary event disclosed in the opening paragraph and is explicitly labeled \"Declaration of Dividend.\" The repurchase authorization increase is secondary. Dividend distributions are material to investors assessing capital allocation and shareholder returns.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:23:32.617629+00:00","company_name":"Dolby Laboratories, Inc.","ticker":"DLB","filing_date":"2026-07-30"}]}